Unlocking Enhanced Efficacy of Aminoglycoside Antibiotics Against Pseudomonas aeruginosa
Microbial Biotechnology · 2025-06 · 18 (6)
DOI: 10.1111/1751-7915.70174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 30.05.2025. Verfasst von Patrick Ofori Tawiah und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Microbiology, Illinois State University, Normal, Illinois, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Aminoglycosides, Anti-Bacterial Agents, Pseudomonas Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Infectious diseases continue to be a global health burden. Among the major human pathogens is the Gram‐negative bacterium Pseudomonas aeruginosa , which is particularly due to its wide range of drug resistance mechanisms. Aminoglycosides, which have long been used in treating pseudomonal infections, are increasingly undermined by resistance. This opinion article discusses the use and challenges of aminoglycosides against P. aeruginosa and highlights recent strategies that enhance aminoglycoside efficacy. These include combinational therapies, metabolic stimulants/adjuvants, silver, and more recently developed derivatives such as AGXX, many of which have been reported to potentiate the cytotoxic effects of aminoglycosides and re‐sensitise aminoglycoside‐resistant strains. While these findings pave the way for future therapies, the clinical relevance of many in vitro studies remains to be investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Microbiology, Illinois State University, Normal, Illinois, USA.
ORCID-Profile: Jan-Ulrik Dahl
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Tawiah, P. O., Sultana, S., & Dahl, J. U. (2025). Unlocking Enhanced Efficacy of Aminoglycoside Antibiotics Against Pseudomonas aeruginosa. Microbial Biotechnology, 18(6). https://doi.org/10.1111/1751-7915.70174
Vancouver
Tawiah PO, Sultana S, Dahl JU. Unlocking Enhanced Efficacy of Aminoglycoside Antibiotics Against Pseudomonas aeruginosa. Microbial Biotechnology. 2025;18(6). doi:10.1111/1751-7915.70174
BibTeX
@article{Tawiah2025,
author = {Tawiah, Patrick Ofori and Sultana, Sadia and Dahl, Jan-Ulrik},
title = {Unlocking Enhanced Efficacy of Aminoglycoside Antibiotics Against Pseudomonas aeruginosa},
journal = {Microbial Biotechnology},
year = {2025},
volume = {18},
number = {6},
doi = {10.1111/1751-7915.70174}
}
EUVIMED